Published in Clin Exp Metastasis on January 16, 2008
Multifunctional mitoxantrone-conjugated magnetic nanosystem for targeted therapy of folate receptor-overexpressing malignant cells. J Nanobiotechnology (2015) 1.52
Selective esterase-ester pair for targeting small molecules with cellular specificity. Proc Natl Acad Sci U S A (2012) 1.19
Altered local and systemic immune profiles underlie lymph node metastasis in breast cancer patients. Int J Cancer (2012) 0.89
The individual-cell-based cryo-chip for the cryopreservation, manipulation and observation of spatially identifiable cells. II: functional activity of cryopreserved cells. BMC Cell Biol (2010) 0.75
In vivo delivery and activation of masked fluorogenic hydrolase substrates by endogenous hydrolases in C. elegans. Chembiochem (2017) 0.75
A cell culture model for T lymphocyte clonal anergy. Science (1990) 9.86
Membrane and cytoplasmic changes in B lymphocytes induced by ligand-surface immunoglobulin interaction. Adv Immunol (1976) 4.18
Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. J Exp Med (1998) 3.04
Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg (1997) 2.49
A high number of tumor free axillary lymph nodes from patients with lymph node negative breast carcinoma is associated with poor outcome. Cancer (2000) 2.20
Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer. PLoS Med (2005) 2.12
Clinical progression of breast cancer malignant behavior: what to expect and when to expect it. J Clin Oncol (2000) 1.78
Escape from immunotherapy: possible mechanisms that influence tumor regression/progression. Cancer Immunol Immunother (2004) 1.44
Adaptation of the cellscan technique for the SCM test in breast cancer. Eur J Cancer (1996) 1.39
The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape. Cancer Immunol Immunother (2004) 1.31
Dendritic cells are dysfunctional in patients with operable breast cancer. Cancer Immunol Immunother (2004) 1.12
Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple mRNA markers. Br J Cancer (2004) 1.11
A novel miniature cell retainer for correlative high-content analysis of individual untethered non-adherent cells. Lab Chip (2006) 1.02
B cell activation. II. Receptor cross-linking by thymus-independent and thymus-dependent antigens induces a rapid decrease in the plasma membrane potential of antigen-binding B lymphocytes. J Immunol (1983) 0.97
EblacZ tumor dormancy in bone marrow and lymph nodes: active control of proliferating tumor cells by CD8+ immune T cells. Cancer Res (1998) 0.96
Survival of patients with metastatic breast cancer: twenty-year data from two SEER registries. BMC Cancer (2004) 0.96
Lymphocyte populations in human lymph nodes. Alterations in CD4+ CD25+ T regulatory cell phenotype and T-cell receptor Vbeta repertoire. Immunology (2003) 0.95
The requirement for esterase activation in the anti-immunoglobulin-triggered movement of B lymphocytes. J Immunol (1976) 0.92
Presentation, management and outcome of axillary recurrence from breast cancer. Am J Surg (2000) 0.92
Breast cancer mortality patterns and time trends in 10 new EU member states: mortality declining in young women, but still increasing in the elderly. Int J Cancer (2004) 0.91
Type 1 and type 2 tumor infiltrating effector cell subpopulations in progressive breast cancer. Clin Immunol (2004) 0.91
Functional analysis of tumor-infiltrating leukocytes in breast cancer patients. J Surg Res (1998) 0.88
Replicative senescence of CD8 T cells: potential effects on cancer immune surveillance and immunotherapy. Cancer Immunol Immunother (2004) 0.86
Occult metastases in sentinel nodes of 200 patients with operable breast cancer. Ann Surg Oncol (2001) 0.86
Expression of activation-related molecules on regional lymph node lymphocytes in human lung cancer. Immunobiology (1996) 0.84
Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis. J Surg Oncol (2004) 0.83
Reverse transcriptase-polymerase chain reaction analysis of cytokeratin 19 expression in the peripheral blood mononuclear cells of normal female blood donors. Mol Pathol (1997) 0.81
Lymph node metastases: the importance of the microenvironment. Cancer (2000) 0.80
Altered lymphocyte populations in tumour invaded nodes of breast cancer patients. Immunol Lett (1993) 0.80
Immune selection in neoplasia: towards a microevolutionary model of cancer development. Br J Cancer (2000) 0.79
Monitoring of intracellular enzyme kinetic characteristics of peripheral mononuclear cells in breast cancer patients. Cancer Epidemiol Biomarkers Prev (2004) 0.79
Analysis of early apoptotic events in individual cells by fluorescence intensity and polarization measurements. Biochem Biophys Res Commun (2002) 0.79
Minimal residual disease in breast cancer. Cancer Metastasis Rev (1999) 0.78
Restoration of tumor-specific HLA class I restricted cytotoxicity in tumor infiltrating lymphocytes of advanced breast cancer patients by in vitro stimulation with tumor antigen-pulsed autologous dendritic cells. Breast Cancer Res Treat (2003) 0.78
Determination of individual cell Michaelis-Menten constants. Cytometry (2002) 0.77
Fluorescence polarisation changes in lymphocyte cytoplasm as a diagnostic test for breast carcinoma. Eur J Cancer (1995) 0.76
A novel approach for on line monitoring of apoptotic cell shrinkage in individual live lymphocytes. J Immunol Methods (2003) 0.75
Vital fluorescence: a new measure of periodontal treatment effect. J Can Dent Assoc (1993) 0.75
Enzyme kinetics. Methods Cell Biol (1994) 0.75
Fluorescence depolarization as an early measure of T lymphocyte stimulation. J Immunol Methods (1997) 0.75
Pathological evaluation of sentinel lymph nodes for breast cancer. Asian J Surg (2004) 0.75
G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol (2002) 6.22
Adrenocortical oncocytic tumors: report of 10 cases and review of the literature. Int J Surg Pathol (2004) 2.58
Positive surgical margins with renal cell carcinoma have a limited influence on long-term oncological outcomes of nephron sparing surgery. Urology (2009) 2.07
Tagging and tracking individual networks within a complex mitochondrial web with photoactivatable GFP. Am J Physiol Cell Physiol (2006) 1.56
The predominance of benign histology in small testicular masses. Urol Oncol (2011) 1.52
A prospective, randomized, controlled, multicenter study of a real-time, intraoperative probe for positive margin detection in breast-conserving surgery. Am J Surg (2008) 1.48
Sex, age, and surgeon decision on nephron-sparing surgery are independent predictors of renal masses with benign histologic findings--a multicenter survey. Urology (2010) 1.46
The characteristics of malignant breast tumors in hormone replacement therapy users versus nonusers. Ann Surg Oncol (2004) 1.45
Advanced non-small cell lung cancer: induction chemotherapy and chemoradiation before operation. Ann Thorac Surg (2002) 1.39
D1 versus D2 Gastrectomy for Gastric Adenocarcinoma. Isr Med Assoc J (2015) 1.39
The prevalence of malignancy in satellite renal lesions and its surgical implication during nephron sparing surgery. J Urol (2007) 1.38
Gastrointestinal stromal tumors: a 19 year experience. Isr Med Assoc J (2009) 1.30
A device for real-time, intraoperative margin assessment in breast-conservation surgery. Am J Surg (2007) 1.22
Angiogenesis in pterygium: morphometric and immunohistochemical study. Curr Eye Res (2002) 1.16
Hyperplastic gastric polyposis, hypergastrinaemia and colorectal neoplasia: a description of four cases. Eur J Gastroenterol Hepatol (2003) 1.05
Large solitary fibrous tumour of the pleura: analysis of six cases. Heart Lung Circ (2007) 1.04
Lymphoma and leukemia cells possess fractal dimensions that correlate with their biological features. Acta Haematol (2008) 1.03
A novel miniature cell retainer for correlative high-content analysis of individual untethered non-adherent cells. Lab Chip (2006) 1.02
Pleomorphic variant of invasive lobular carcinoma of the male breast. Virchows Arch (2005) 1.01
Diagnostic performance of a novel device for real-time margin assessment in lumpectomy specimens. J Surg Res (2009) 1.01
Epidermoid cyst and teratoma of the testis: sonographic and histologic similarities. J Ultrasound Med (2005) 0.95
Serum DNA methylation for monitoring response to neoadjuvant chemotherapy in breast cancer patients. Int J Cancer (2012) 0.94
Incidental finding of gallbladder carcinoma. Isr Med Assoc J (2002) 0.91
Gastrointestinal carcinomas occurring in breast cancer patients. Breast J (2006) 0.89
Mondor's disease of the axilla: a rare complication of sentinel node biopsy. Breast J (2004) 0.88
Electrical impedance scanning as a new breast cancer risk stratification tool for young women. J Surg Oncol (2008) 0.88
Saturation prostate biopsy in high risk patients after multiple previous negative biopsies. Urology (2008) 0.87
Differentiated thyroid carcinoma in children and young adults: evaluation of response to treatment. Clin Nucl Med (2005) 0.86
The accuracy of sentinel node mapping according to T stage in patients with gastric cancer. Gastric Cancer (2010) 0.86
The immunohistochemistry profile of lymphocytic gastritis in celiac disease and helicobacter pylori infection: interplay between infection and inflammation. Mediators Inflamm (2007) 0.85
Can hamartoma of the breast be distinguished from fibroadenoma using fine-needle aspiration cytology? Diagn Cytopathol (2006) 0.85
A polymer microstructure array for the formation, culturing, and high throughput drug screening of breast cancer spheroids. Biomaterials (2010) 0.85
Diagnostic value of estrogen receptors in thyroid lesions. Med Sci Monit (2010) 0.85
Leydig cell tumors of the testis: gray scale and color Doppler sonographic appearance. J Ultrasound Med (2004) 0.84
Testicular sparing surgery for small masses. Urol Oncol (2010) 0.83
Epithelioid hemangioendothelioma as a rare cause of blue toe syndrome. J Vasc Surg (2011) 0.83
Renal oncocytoma--are there sufficient grounds to consider surveillance following prenephrectomy histologic diagnosis. Urol Oncol (2010) 0.83
Fatal Rickettsia conorii subsp. israelensis infection, Israel. Emerg Infect Dis (2008) 0.82
Is the diagnostic yield of prostate needle biopsies affected by prostate volume? Urol Oncol (2011) 0.82
Comparative analysis of cell parameter groups for breast cancer detection. Comput Methods Programs Biomed (2009) 0.82
Breast hamartoma: fine-needle aspiration cytologic finding. Cancer (2003) 0.81
Induction of biologically active antineutrophil cytoplasmic antibodies by immunization with human apoptotic polymorphonuclear leukocytes. Clin Immunol (2002) 0.81
Tissue spectroscope: a novel in vivo approach to real time monitoring of tissue vitality. J Biomed Opt (2004) 0.81
A similar cell-specific pattern of HOXA methylation in normal and in cancer tissues. Epigenetics (2010) 0.81
Are estrogen receptors alpha detectable in normal and abnormal thyroid tissue? Eur Arch Otorhinolaryngol (2010) 0.80
The information-theory analysis of Michaelis-Menten constants for detection of breast cancer. Cancer Detect Prev (2007) 0.80
Quick parathormone assay in the surgical management of hyperparathyroidism. Isr Med Assoc J (2003) 0.80
Proteinase-activated receptors differentially modulate in vitro invasion of human pancreatic adenocarcinoma PANC-1 cells in correlation with changes in the expression of CDC42 protein. Pancreas (2014) 0.80
The individual-cell-based cryo-chip for the cryopreservation, manipulation and observation of spatially identifiable cells. I: methodology. BMC Cell Biol (2010) 0.80
Factors affecting rise in the incidence of infiltrating lobular carcinoma of the breast. Isr Med Assoc J (2010) 0.80
The immunosuppressive effect of methotrexate in active rheumatoid arthritis patients vs. its stimulatory effect in nonactive patients, as indicated by cytometric measurements of CD4+ T cell subpopulations. Immunol Invest (2004) 0.79
COX2 expression in high-grade breast cancer: evidence for prognostic significance in the subset of triple-negative breast cancer patients. Med Oncol (2014) 0.79
Polymer live-cell array for real-time kinetic imaging of immune cells. Biomaterials (2010) 0.79
Fluorescence resonance energy transfers measurements on cell surfaces via fluorescence polarization. Biophys J (2002) 0.79
Comparative study of the pathological characteristics of gastric stump carcinoma and carcinoma of the upper third of the stomach. Isr Med Assoc J (2011) 0.79
Tracing apoptosis and stimulation in individual cells by fluorescence intensity and anisotropy decay. J Biomed Opt (2005) 0.79
Monitoring the apoptotic process induced by oxidized low-density lipoprotein in Jurkat T-lymphoblast and U937 monocytic human cell lines. Cell Biochem Biophys (2004) 0.79
Mitochondrial function and tissue vitality: bench-to-bedside real-time optical monitoring system. J Biomed Opt (2011) 0.79
Monitoring of intracellular enzyme kinetic characteristics of peripheral mononuclear cells in breast cancer patients. Cancer Epidemiol Biomarkers Prev (2004) 0.79
The estrogen receptors in the papillary carcinoma of the thyroid gland. Oncol Res (2010) 0.78
Combined system for the simultaneous optical and electrochemical monitoring of intra- and extracellular NO produced by glioblastoma cells. Anal Chem (2005) 0.78
The induction of apoptosis by methotrexate in activated lymphocytes as indicated by fluorescence hyperpolarization: a possible model for predicting methotrexate therapy for rheumatoid arthritis patients. Cell Struct Funct (2003) 0.78
Pattern projection for subpixel resolved imaging in microscopy. Micron (2006) 0.78
Lymphocyte resistance to lysophosphatidylcholine mediated apoptosis in atherosclerosis. Atherosclerosis (2006) 0.78
Concomitant real-time monitoring of intracellular reactive oxygen species and mitochondrial membrane potential in individual living promonocytic cells. J Immunol Methods (2006) 0.78
Unusual manifestations of myelofibrosis in a patient with congenital asplenia. Acta Haematol (2007) 0.78
Decreased IGF-1 levels potentiate association of inflammation with all-cause and cardiovascular mortality in prevalent hemodialysis patients. Growth Horm IGF Res (2013) 0.78
Ratiometric fluorescence polarization as a cytometric functional parameter: theory and practice. Phys Med Biol (2003) 0.77
Determination of individual cell Michaelis-Menten constants. Cytometry (2002) 0.77
Predominance of younger age, advanced stage, poorly-differentiated and mucinous histology in Israeli Arab patients with colorectal cancer. Anticancer Res (2006) 0.77